NAME | DATE | TM | OPP | MIN | PTS | REB | AST | STL | BLK | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | TS% | OREB | DREB | TOV | PF | +/- | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | T. Maxey | 12/16/2024 | PHI | @ | CHA | 40 | 40 | 5 | 5 | 4 | 0 | 12 | 28 | 42.9 | 6 | 12 | 50.0 | 10 | 13 | 76.9 | 59.3 | 1 | 4 | 4 | 3 | +18 | |
2 | T. Maxey | 12/20/2024 | PHI | vs | CHA | 38 | 23 | 4 | 6 | 1 | 1 | 9 | 18 | 50.0 | 4 | 11 | 36.4 | 1 | 2 | 50.0 | 60.9 | 0 | 4 | 2 | 1 | +16 | |
3 | T. Maxey | 12/21/2024 | PHI | @ | CLE | 33 | 27 | 1 | 3 | 1 | 0 | 8 | 21 | 38.1 | 5 | 10 | 50.0 | 6 | 8 | 75.0 | 55.1 | 0 | 1 | 1 | 0 | -24 | |
4 | T. Maxey | 12/23/2024 | PHI | vs | SAS | 41 | 32 | 10 | 8 | 3 | 0 | 12 | 25 | 48.0 | 5 | 11 | 45.5 | 3 | 5 | 60.0 | 58.8 | 0 | 10 | 1 | 1 | +7 | |
5 | T. Maxey | 12/25/2024 | PHI | @ | BOS | 41 | 33 | 4 | 12 | 3 | 1 | 12 | 23 | 52.2 | 3 | 9 | 33.3 | 6 | 6 | 100.0 | 64.4 | 1 | 3 | 3 | 2 | +7 | |
6 | T. Maxey | 12/28/2024 | PHI | @ | UTA | 41 | 32 | 0 | 6 | 2 | 1 | 9 | 23 | 39.1 | 5 | 13 | 38.5 | 9 | 10 | 90.0 | 58.4 | 0 | 0 | 2 | 3 | -2 | |
7 | T. Maxey | 12/30/2024 | PHI | @ | POR | 36 | 23 | 1 | 3 | 1 | 0 | 7 | 13 | 53.8 | 3 | 7 | 42.9 | 6 | 6 | 100.0 | 73.5 | 0 | 1 | 4 | 4 | +14 | |
8 | T. Maxey | 1/1/2025 | PHI | @ | SAC | 42 | 27 | 2 | 7 | 5 | 1 | 10 | 23 | 43.5 | 3 | 10 | 30.0 | 4 | 4 | 100.0 | 54.5 | 0 | 2 | 4 | 3 | -9 | |
9 | T. Maxey | 1/2/2025 | PHI | @ | GSW | 32 | 14 | 3 | 6 | 4 | 2 | 4 | 13 | 30.8 | 2 | 6 | 33.3 | 4 | 4 | 100.0 | 47.4 | 0 | 3 | 3 | 2 | -24 | |
10 | T. Maxey | 1/4/2025 | PHI | @ | BKN | 32 | 18 | 2 | 7 | 0 | 0 | 5 | 12 | 41.7 | 2 | 6 | 33.3 | 6 | 7 | 85.7 | 59.7 | 0 | 2 | 4 | 0 | +20 | |
11 | T. Maxey | 1/6/2025 | PHI | vs | PHX | 44 | 31 | 0 | 10 | 2 | 0 | 11 | 25 | 44.0 | 6 | 14 | 42.9 | 3 | 5 | 60.0 | 57.0 | 0 | 0 | 4 | 1 | -5 | |
12 | T. Maxey | 1/8/2025 | PHI | vs | WAS | 39 | 29 | 3 | 6 | 2 | 0 | 11 | 27 | 40.7 | 3 | 14 | 21.4 | 4 | 6 | 66.7 | 48.9 | 0 | 3 | 1 | 2 | +13 | |
13 | T. Maxey | 1/10/2025 | PHI | vs | NOP | 41 | 30 | 6 | 12 | 1 | 0 | 10 | 20 | 50.0 | 2 | 8 | 25.0 | 8 | 8 | 100.0 | 63.8 | 2 | 4 | 1 | 1 | 0 | |
14 | T. Maxey | 1/12/2025 | PHI | @ | ORL | 39 | 29 | 4 | 5 | 3 | 0 | 7 | 19 | 36.8 | 3 | 9 | 33.3 | 12 | 13 | 92.3 | 58.7 | 0 | 4 | 6 | 4 | -1 | |
15 | T. Maxey | 1/15/2025 | PHI | vs | NYK | 46 | 33 | 6 | 6 | 1 | 1 | 13 | 32 | 40.6 | 2 | 9 | 22.2 | 5 | 5 | 100.0 | 48.2 | 2 | 4 | 4 | 3 | -9 | |
Average | 38.8 | 28.1 | 3.4 | 6.8 | 2.2 | 0.5 | 9.3 | 21.5 | 43.5 | 3.6 | 9.9 | 36.2 | 5.8 | 6.8 | 85.3 | 57.4 | 0.4 | 3.0 | 2.9 | 2.0 | 1.4 | ||||||
Total | 582 | 421 | 51 | 102 | 33 | 7 | 140 | 322 | 43.5 | 54 | 149 | 36.2 | 87 | 102 | 85.3 | 57.4 | 6 | 45 | 44 | 30 | +21 |
ORTG
110.3
24th
DRTG
114.1
19th
NETRTG
-3.7
23rd
3P%
34.2
24th